192 related articles for article (PubMed ID: 37524874)
1. SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways.
Ren X; Feng C; Wang Y; Chen P; Wang S; Wang J; Cao H; Li Y; Ji M; Hou P
Exp Mol Med; 2023 Aug; 55(8):1757-1769. PubMed ID: 37524874
[TBL] [Abstract][Full Text] [Related]
2. ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly.
Wu S; Chen M; Huang J; Zhang F; Lv Z; Jia Y; Cui YZ; Sun LZ; Wang Y; Tang Y; Verhoeft KR; Li Y; Qin Y; Lin X; Guan XY; Lam KO
Cancer Res; 2021 Feb; 81(4):986-1000. PubMed ID: 33310726
[TBL] [Abstract][Full Text] [Related]
3. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K/AKT and MAPK/ERK signaling pathways in gastric cancer.
Li JF; Li WH; Xue LL; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):588-597. PubMed ID: 30720166
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways.
Li SL; Chen X; Wu T; Zhang XW; Li H; Zhang Y; Ji ZZ
Biomed Pharmacother; 2018 Nov; 107():841-848. PubMed ID: 30142546
[TBL] [Abstract][Full Text] [Related]
6. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
7. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
8. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
9. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
[TBL] [Abstract][Full Text] [Related]
10. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
11. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
[TBL] [Abstract][Full Text] [Related]
12. miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop.
Zhang F; Li K; Pan M; Li W; Wu J; Li M; Zhao L; Wang H
J Exp Clin Cancer Res; 2018 Jul; 37(1):152. PubMed ID: 30012200
[TBL] [Abstract][Full Text] [Related]
13. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
Zhang C; Lin X; Zhao Q; Wang Y; Jiang F; Ji C; Li Y; Gao J; Li J; Shen L
J Cancer Res Clin Oncol; 2020 Feb; 146(2):329-342. PubMed ID: 31912229
[TBL] [Abstract][Full Text] [Related]
14. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.
Shi R; Yang Z; Liu W; Liu B; Xu Z; Zhang Z
Oncol Rep; 2014 Feb; 31(2):812-8. PubMed ID: 24297051
[TBL] [Abstract][Full Text] [Related]
16. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
[TBL] [Abstract][Full Text] [Related]
17. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
Chen DL; Zeng ZL; Yang J; Ren C; Wang DS; Wu WJ; Xu RH
J Hematol Oncol; 2013 Jun; 6():43. PubMed ID: 23806079
[TBL] [Abstract][Full Text] [Related]
18. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
[TBL] [Abstract][Full Text] [Related]
19. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
[TBL] [Abstract][Full Text] [Related]
20. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
